Nemec Sarah

Senior VP, Finance and PAOBolt Biotherapeutics, Inc. (BOLT) · full profile →Form 4 · filed Oct 24, 2025
Net Buying
Open-Market Buys
$686
Open-Market Sells
$0
Net Open-Market Flow
$686
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 22, 2025Grant(A)23K$024K
Jun 6, 2025Buy(P)125$5.49$686943

Transaction Codes

A
Grant / award
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-250334) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.